Raja Kumaraguru
Stock Analyst at Roth MKM
(n/a)
# 4,576
Out of 4,937 analysts
5
Total ratings
n/a
Success rate
-43.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Raja Kumaraguru
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAIN Rain Enhancement Technologies Holdco | Downgrades: Neutral | $1.2 | $3.46 | -65.32% | 1 | May 30, 2023 | |
| NLSP NLS Pharmaceutics AG | Initiates: Buy | $480 | $2.14 | +22,329.91% | 1 | Mar 12, 2021 | |
| CNSP CNS Pharmaceuticals | Initiates: Buy | $9,000,000 | $6.70 | +134,328,258.21% | 1 | Feb 2, 2021 | |
| FBRX Forte Biosciences | Initiates: Buy | $2,250 | $10.18 | +22,013.02% | 1 | Aug 28, 2020 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $210 | $34.65 | +506.06% | 1 | Feb 19, 2020 |
Rain Enhancement Technologies Holdco
May 30, 2023
Downgrades: Neutral
Price Target: $1.2
Current: $3.46
Upside: -65.32%
NLS Pharmaceutics AG
Mar 12, 2021
Initiates: Buy
Price Target: $480
Current: $2.14
Upside: +22,329.91%
CNS Pharmaceuticals
Feb 2, 2021
Initiates: Buy
Price Target: $9,000,000
Current: $6.70
Upside: +134,328,258.21%
Forte Biosciences
Aug 28, 2020
Initiates: Buy
Price Target: $2,250
Current: $10.18
Upside: +22,013.02%
Monopar Therapeutics
Feb 19, 2020
Initiates: Buy
Price Target: $210
Current: $34.65
Upside: +506.06%